Novavax Licenses Matrix-M Vaccine Technology to Pfizer in Strategic Development Deal
Novavax has entered into a licensing agreement with Pfizer that allows the global pharmaceutical major to use Novavax’s Matrix-M adjuvant […]
Novavax has entered into a licensing agreement with Pfizer that allows the global pharmaceutical major to use Novavax’s Matrix-M adjuvant […]
Pfizer will exit ViiV Healthcare through a transaction valued at approximately USD 1.9 billion, leading to a major change in […]
US pharma major Pfizer and Johnson & Johnson (J&J) are yet to seek Emergency Use Authorization or EUA for their […]
The Pfizer Inc and BioNTech SE Covid-19 vaccines have appeared to stop the vast majority of recipients in Israel from […]
Pfizer Inc has declared it had withdrawn an application for emergency-use authorisation of its Covid-19 vaccine in India, after failing […]
Twenty-three people died in Norway within days of receiving their first dose of the Pfizer COVID-19 vaccine, with 13 of […]
USFDA has given a green signal to pharma major Pfizer Incs manufactured antibody-drug conjugate (ADC), Besponsa or inotuzumab ozogamicin, used […]
Pfizer Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted […]
American global pharmaceutical major Pfizer has decided to withdraw its popular Corex brand of cough syrup formulation and extend the […]
Pfizers GEP (Global Established Products) division in India announced the launch of its largest selling antacid Gelusil liquid in a […]
Manipal Hospitals and Narayana Health have got together with an investor to provide up to Rs 10 crore in grants […]
Pharma giant Pfizer is alleged cutting down its work force in India by insisting they retire voluntarily. The company has […]
Recently Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has declined the request from major pharma firms to increase the […]